secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001193125-23-088225
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharmaceuticals board member Philip H. Coelho to retire at 2023 annual meeting
--------------------------------------------------------------------------------

- Philip H. Coelho, independent director since 2002, will not stand for reelection.
- Coelho serves as Chair of Nominating/Corporate Governance Committee and on Audit Committee.
- Retirement is not due to any disagreement with the company.
- He will continue as director until term expires at the 2023 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/0001193125-23-088225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/d469581d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-088225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer